Skip to content

A investigation of biomarker in neonatal respiratory distress syndrome

A investigation of biomarker in neonatal respiratory distress syndrome

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029383
Enrollment
Unknown
Registered
2020-01-27
Start date
2020-02-01
Completion date
Unknown
Last updated
2020-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal respiratory distress syndrome

Interventions

Patients with progressive dyspnea:Nil
Patients without respiratory diseases:Nil

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 0.1 Years

Inclusion criteria

Inclusion criteria: Patients with progressive dyspnea from 1 to 28 days after birth.

Exclusion criteria

Exclusion criteria: 1. Complex congenital heart disease; 2. Severe developmental malformations (diaphragmatic hernia, esophagotracheal fistula, etc.).

Design outcomes

Primary

MeasureTime frame
IL-17;

Countries

China

Contacts

Public ContactShi Yuan

Children's Hospital of Chongqing Medical University

doctor_mer@163.com+86 13508300283

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026